MiR-134 expression in peripheral blood in patients with epilepsy / 中风与神经疾病杂志
Journal of Apoplexy and Nervous Diseases
; (12): 154-157, 2020.
Article
en Zh
| WPRIM
| ID: wpr-1039812
Biblioteca responsable:
WPRO
ABSTRACT
@#Objective To investigate the difference and significance in the expression of miR-134 in peripheral blood of patients with epilepsy.Methods Trizol was used to extract serum RNAs of patients with epilepsy,NCode TM VILO TM micrornas cDNA short Kit and Express Sybr those TM micrornas qRTPCR Kits was used to reverse transcriptions and real-time fluorescent quantitative PCR to detect the expression of miR-134.All cases were grouped according to the course of disease,seizure frequency,onset time limit,brain electrical activity and special epilepsy syndrome.Results Compared with control group,the expression of miR-134 in peripheral blood of epilepsy group is significantly increased,it is obviously higher in long course group and acute group.The expression of miR-134 in different seizure frequency group and special epilepsy syndrome group has no difference.Conclusion The expression of miR-134 in peripheral blood of patients with epilepsy was significantly increased while it was affected by the length of disease and the duration of seizure.In addition,the expression of miR-134 in peripheral blood of patients with epilepsy was positively correlated with the degree of discharge and severity of damage,indicating that miR-134 could be a biomarker for epilepsy.
Buscar en Google
Índice:
WPRIM
Idioma:
Zh
Revista:
Journal of Apoplexy and Nervous Diseases
Año:
2020
Tipo del documento:
Article